Saturday, October 27, 2018

Awards for Distinction in ICIS Annual Cancer Imaging Conference- France/2018

The INTERNATIONAL CANCER IMAGING SOCIETY (ICIS) conducted its 18th Annual Teaching Course in Palais de L'Europe, Menton France on Oct 7-9th of this year.  Since its first ICIS Conference (2000) in London, UK, the educational summits have continued to receive global recognition for advanced education in the community of multidisciplinary cancer professionals. The society runs an annual teaching course as well as hands-on computer workshops on prostate, pancreatic, hepatobiliary, gynecological, thoracic cancers and oncological MRI.  Cancer Imaging is the official journal of the ICIS and is published by BMC and is a journal publishing original articles, reviews and editorials written by expert international radiologists encompassing CT, MRI, PET, ultrasound, radionuclide and multimodal imaging in all kinds of malignant tumors plus new developments, techniques and innovations.

The event also recognizes leaderships in various categories of discipline and welcomes speakers and poster presentations at the annual event.   Among the honorees, President Prof. Wim Oyen and Prof. Evis Sala, head of the Scientific Committee congratulates Dr. Robert Bard for his distinction in his multi-poster presentation on the 3D Doppler Mapping of cutaneous and subcutaneous lymphoma.

Other winners of this worldwide conference include:
- Jennifer Golia Pernicka for her abstract entitled 'CT radiomic features predict microsatellite instability in colorectal cancer'
- Kate Potter for 'MRI findings following Papillon contact X-ray brachytherapy for rectal cancer'.
- Christina Pfannenberg for 'Generating evidence for clinical benefit of PET/CT: Results of the first oncologic PET/CT registry in Germany'

This global medical event continues its annual tradition with next year's event to take place in Gran Guardia, Verona Italy on October 7th-9th, 2019. For more information, visit the ICIS website or click this event link.

Disclaimer & Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.